Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells

Cell Growth and Differentiation

Volumn 12, Issue 3, 2001, Pages 129-135

  Price, D J ^a   Miralem, T ^a   Jiang, S ^a   Steinberg, R ^a   Avraham, H ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; IODINE 125; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL COMMUNICATION; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LYMPHOKINES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NEUREGULIN-1; PHOSPHORYLATION; PROTEINS; PROTEOGLYCANS; RADIOLIGAND ASSAY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034925637     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function
2. What, if anything, is an angiogenic factor?
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Vascular endothelial growth factor and its receptors
5. Vascular endothelial growth factor (VEGF) and its receptors
6. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival
7. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
8. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma
9. Angiogenic growth factors in preinvasive breast disease
10. Serum VEGF levels in women with a benign breast tumor or breast cancer
11. Vascular endothelial growth factor is a secreted angiogenic mitogen
12. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
13. Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family
14. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
15. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
16. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165
17. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
18. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
19. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
20. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
21. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain
22. Neuropilin-1 is expressed by endothelial and specific receptor for vascular endothelial growth factor
23. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor
24. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer
25. Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer
26. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells
27. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
28. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
29. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
30. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
31. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparin sulfates for efficient binding to the VEGF receptors of human melanoma cells
32. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF
33. Vascular endothelial growth factor (VEGF) in human prostate cancer: More than angiogenesis
34. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma
35. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
36. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase
37. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling
38. Cellular survival: A play in three Akts
39. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily
40. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily
41. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
42. Production of VEGF and expression of the VEGF receptors Fit-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours
43. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation
44. The meaning of scatchard and hill plots
45. An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3-kinase and phospholipase C